Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
Caruso G*, Grasso M, Fidilio A, Torrisi SA, Musso [...]
December 2021
May 2020
Antidepressant drugs and physical activity: a possible synergism in the treatment of major depression?
Guerrera CV, Furneri G, Grasso M, Caruso G, Castel [...]
September 2019
The many faces of mitochondrial dysfunction in depression: from pathology to treatment
Caruso G, Benatti C, Blom JMC, Caraci F, Tascedda [...]
June 2019
-
Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by Aβ 1-42 oligomers in mice: a key role of transforming growth factor-β1Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by Aβ 1-42 oligomers in mice: a key role of transforming growth factor-β1
-
-
-
-
-
-
Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by Aβ 1-42 oligomers in mice: a key role of transforming growth factor-β1
Torrisi SA, Geraci F, Tropea MR, Grasso M, Caruso [...]
February 2019
Inflammation as the common biological link between depression and cardiovascular diseases: can carnosine exert a protective role?
Caruso G*, Fresta CG, Grasso M, Santangelo R, Lazz [...]
April 2018
Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target
Caraci F, Spampinato SF, Morgese MG, Tascedda F, S [...]